UnitedHealth Group Incorporated’s (UNH) Q1 earnings exceeded market estimates, reporting an adjusted profit of $5.49, up 3.4% from a strong year-ago quarter and 11 cents ahead of estimates. Revenue increased 14.2% to $80.149 billion, above estimates of $79 billion. The medical cost ratio, paid benefits as a share of premiums, increased to 82% versus 80.9% in the year-ago quarter, partly related to Covid impacts.
Medical membership rose 335,000 from Q4, as UNH added 400,000 Medicare Advantage members and 155,000 Medicaid members. The company raised full-year earnings guidance to a range of $21.20 to $21.70, up from $21.10-$21.60. Analysts were expecting $21.60, representing a 13.6% growth from a year ago.
If you liked this story please consider, visiting the Atossa Therapeutics (ATOS) dedicated page at Vista Partners to learn about the Seattle-based biotech firm’s work towards finding therapeutic treatments for Breast Cancer and the Coronavirus.
Vista Partners LLC (”Vista”) is a California Registered Investment Advisor based in San Francisco. Vista delivers timely and relevant insights via the website: www.vistapglobal.com with daily stories, weekly market updates, monthly macroeconomic newsletters, podcasts, & Vista’s proprietary equity and market research to help you stay informed and stay competitive. Vista’s mission is to invest partner capital while arming investors with a comprehensive global financial perspective across all market sectors. Vista also seeks to provide select issuers with actionable advice regarding fundamental development, corporate governance, and capital market directives.
Stay Informed! Stay Competitive! Please join us at Vista Partners, receive our FREE email updates throughout the week, and view our exclusive content and research.